Moya S. Cunningham
St. Luke's Hospital · 39 works · 1,287 citations · h-index 18
Top works
- Radiotherapy equipment and departments in the European countries: Final results from the ESTRO-HERO survey
- Radiotherapy staffing in the European countries: Final results from the ESTRO-HERO survey
- Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial
- Guidelines for equipment and staffing of radiotherapy facilities in the European countries: Final results of the ESTRO-HERO survey
- ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)
- ICORG 10-14: Neo-AEGIS: A randomized clinical trial of neoadjuvant and adjuvant chemotherapy (modified MAGIC regimen) versus neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the esophagus and esophagogastric junction.
- Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452).
- CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma
- Primary thromboprophylaxis for cancer patients with central venous catheters – a reappraisal of the evidence
- Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement
- Does antithrombotic therapy improve survival in cancer patients?
- Subjective taste and smell changes in treatment-naive people with solid tumours
- Uveal Melanoma in Ireland
- Management of refractory venous thrombosis associated with malignancy using a supra-therapeutic enoxaparin regimen
- Prevention and Management of Venous Thromboembolism in People with Cancer: A Review of the Evidence
- Neo-AEGIS (Neoadjuvant Trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Final primary outcome analysis.
- Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial
- Outcomes for Esophageal Squamous Cell Carcinoma Treated with Curative Intent in a Western Cohort: Should Multimodal Therapy Be the Gold Standard?
- Quality of Life in Uveal Melanoma Patients in Ireland: A Single-Centre Survey
- Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21)